Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.
Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.
Several studies were presented that examined how immunotherapy, such as Keytruda (pembrolizumab) in triple-negative breast cancer, could provide benefit to different groups of patients.
"We look forward to the field of immunology much more and expect to see more progress, although it's not going to be dramatic, one big fell swoop at a time," he says. "We're going to make step-wise improvements in this area as we learn more about the immunology pathways as they pertain to breast cancer."
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen
Rethinking Physical and Mental Health Throughout the Breast Cancer Journey
March 17th 2024A patient advocate and oncology nurse discuss the importance of physical and mental health during the breast cancer journey during a panel session at the CURE® Educated Patient® Breast Cancer Summit.
Read More
Olivia Munn Discusses Breast Cancer, Christine Brinkley Diagnosed With Basal Cell Carcinoma and More
March 15th 2024From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.
Read More